Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53,160,953
-
Total 13F shares
-
28,647,438
-
Share change
-
-4,382,286
-
Total reported value
-
$23,897,708
-
Put/Call ratio
-
14%
-
Price per share
-
$0.83
-
Number of holders
-
109
-
Value change
-
-$3,342,214
-
Number of buys
-
39
-
Number of sells
-
61
Institutional Holders of AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) as of Q4 2023
As of 31 Dec 2023,
AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,647,438 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, SILVERBACK ASSET MANAGEMENT LLC, Senvest Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Herald Investment Management Ltd, STATE STREET CORP, Sargent Investment Group, LLC, UBS OCONNOR LLC, and West Tower Group, LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.